SCHEMBL650350

SCHEMBL650350

CCCCn1c(-c2ccccc2)nc(C(=O)OCC)c1CN(Cc1ccc2c(c1)OCO2)Cc1ccc2c(c1)OCO2

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.59
SIRT2 Q8IXJ6 2/20 0.49
CYP19A1 P11511 1/20 0.47
TSHR P16473 2/20 0.46
SMN1; SMN2 Q16637 5/20 0.44
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 2/20 0.44
TP53 P04637 2/20 0.44
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43
PKM P14618 1/20 0.43
LMNA P02545 3/20 0.43
ELANE P08246 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SIRT1 Q96EB6 1/20 0.42
DHODH Q02127 1/20 0.42
ALDH1A1 P00352 4/20 0.41
ALOX15 P16050 2/20 0.41
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650920 0.93 C5AR1 (0.59) C5AR1SIRT2CYP19A1TSHRSMN1; SMN2
SCHEMBL650114 0.91 C5AR1 (0.63) C5AR1SIRT2TSHRSMN1; SMN2KDM4E
SCHEMBL648699 0.91 C5AR1 (0.57) C5AR1SIRT2CYP19A1TSHRSMN1; SMN2
SCHEMBL648214 0.91 C5AR1 (0.62) C5AR1SIRT2TSHRSMN1; SMN2KDM4E
Dimethylamine SCHEMBL653060 0.89 C5AR1 (0.60) C5AR1SIRT2TSHRSMN1; SMN2KDM4E
SCHEMBL648143 0.89 C5AR1 (0.60) C5AR1SIRT2TSHRSMN1; SMN2PPARG
SCHEMBL648164 0.86 C5AR1 (0.57) C5AR1SIRT2TSHRSMN1; SMN2KDM4E
SCHEMBL1913049 0.86 C5AR1 (0.67) C5AR1SIRT2TSHRSMN1; SMN2HSD17B10
SCHEMBL648161 0.86 C5AR1 (0.55) C5AR1SIRT2CYP19A1TSHRSMN1; SMN2
SCHEMBL1913029 0.85 C5AR1 (0.62) C5AR1SIRT2TSHRSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed